An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Clinical trial NCT05626751 · TERMINATED

Trial details

NCT number: NCT05626751
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Cutaneous Systemic Sclerosis Sclerosis, Systemic

Start date: 2022-11-04
Primary completion: 2025-02-24
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.